CVA
CNMD icon

Ceredex Value Advisors’s CONMED CNMD Stock Holding History

Ceredex Value Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-325,046
Closed -$42.5M – 141
2021
Q1 		$42.5M Sell
325,046
-18,500
-5% -$2.23M 0.49% 77
2020
Q4 		$38.5M Buy
343,546
+746
+0.2% +$70.6K 0.49% 74
2020
Q3 		$27M Buy
342,800
+16,300
+5% +$1.33M 0.4% 74
2020
Q2 		$23.6M Buy
+326,500
New +$22.7M 0.35% 89

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ceredex Value Advisors's CNMD Position: Q2 2021 in Review

Ceredex Value Advisors sold out of CONMED (CNMD) in Q2 2021, closing a stake of 325,046 shares — an estimated $42.5M sold.

Ceredex Value Advisors first reported a position in CNMD in Q2 2020 and held it in 4 quarters. The position peaked at $42.5M in Q1 2021. 252 funds tracked by Wall St. Rank hold CNMD as of Q2 2021.

  • Ceredex Value Advisors reported no remaining CONMED position as of Q2 2021 after selling out during the quarter.
  • Ceredex Value Advisors sold 325,046 CONMED shares in Q2 2021, an estimated $42.5M.
  • Ceredex Value Advisors first reported a position in CONMED in Q2 2020 and held it in 4 quarters.
  • Ceredex Value Advisors's CONMED position peaked at $42.5M in Q1 2021.
  • 252 funds tracked by Wall St. Rank held CONMED as of Q2 2021.

Based on Ceredex Value Advisors's 13F filing for Q2 2021, filed 3 Aug 2021.